Словакия - словашки - ŠÚKL (Štátny ústav pre kontrolu liečiv)

diawin deutschland gmbh berliner strasse 75 630 65 offenbach am main nemecko -

Словакия - словашки - ŠÚKL (Štátny ústav pre kontrolu liečiv)

diawin deutschland gmbh berliner strasse 75 630 65 offenbach am main nemecko -

Словакия - словашки - ŠÚKL (Štátny ústav pre kontrolu liečiv)

diawin deutschland gmbh berliner strasse 75 630 65 offenbach am main nemecko -

Словакия - словашки - ŠÚKL (Štátny ústav pre kontrolu liečiv)

diawin deutschland gmbh berliner strasse 75 630 65 offenbach am main nemecko -

Европейски съюз - словашки - EMA (European Medicines Agency)

novartis europharm limited - secukinumab - arthritis, psoriatic; psoriasis; spondylitis, ankylosing - imunosupresíva - plaque psoriasiscosentyx is indicated for the treatment of moderate to severe plaque psoriasis in adults and children from the age of 6 years old who are candidates for systemic therapy. hidradenitis suppurativa (hs)cosentyx is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adults with an inadequate response to conventional systemic hs therapy. psoriatická arthritiscosentyx, samostatne alebo v kombinácii s metotrexátom (mtx), je indikovaná na liečbu aktívnej psoriatická artritída u dospelých pacientov, keď reakcia na predchádzajúce ochorenia úprava anti reumatických drog (dmard) terapia bola neprimeraná. axiálne spondyloarthritis (axspa)ankylozujúca spondylitída (as, radiographic axiálne spondyloarthritis)cosentyx je indikovaná na liečbu aktívnej ankylozujúcej spondylitíde u dospelých, ktorí reagovali neadekvátne konvenčná terapia. non-radiographic axial spondyloarthritis (nr-axspa)cosentyx is indicated for the treatment of active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri) evidence in adults who have responded inadequately to non steroidal anti inflammatory drugs (nsaids). juvenile idiopathic arthritis (jia)enthesitis-related arthritis (era)cosentyx, alone or in combination with methotrexate (mtx), is indicated for the treatment of active enthesitis-related arthritis in patients 6 years and older whose disease has responded inadequately to, or who cannot tolerate, conventional therapy. juvenile psoriatic arthritis (jpsa)cosentyx, alone or in combination with methotrexate (mtx), is indicated for the treatment of active juvenile psoriatic arthritis in patients 6 years and older whose disease has responded inadequately to, or who cannot tolerate, conventional therapy.

Европейски съюз - словашки - EMA (European Medicines Agency)

abbvie deutschland gmbh co. kg - adalimumab - spondylitis, ankylosing; arthritis, juvenile rheumatoid; uveitis; colitis, ulcerative; psoriasis; arthritis, psoriatic; crohn disease; arthritis, rheumatoid - imunosupresíva - pozrite si dokument s informáciami o produkte.

Европейски съюз - словашки - EMA (European Medicines Agency)

novartis europharm ltd. - aliskiren - vysoký tlak - Činidlá pôsobiace na systém renín-angiotenzín - liečba esenciálnej hypertenzie.

Словакия - словашки - ŠÚKL (Štátny ústav pre kontrolu liečiv)

mobiak s.a kathiana akrotiriou-chania crete grécko -

Словакия - словашки - ŠÚKL (Štátny ústav pre kontrolu liečiv)

haleon czech republic s.r.o., Česká republika - paracetamol - 07 - analgetica, antipyretica

Словакия - словашки - ŠÚKL (Štátny ústav pre kontrolu liečiv)

reckitt benckiser (czech republic), spol. s r.o. , Česká republika - ibuprofén - 29 - antirheumatica, antiphlogistica, antiuratica